Marker Therapeutics Inc (MRKR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,192 | 9,000 | 7,801 | 11,323 | 15,112 |
| Receivables | 2,347 | 744 | 2,490 | 1,852 | 1,028 |
| TOTAL | $22,023 | $10,910 | $11,675 | $14,092 | $17,127 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $22,023 | $10,910 | $11,675 | $14,092 | $17,127 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,711 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,754 | 3,461 | 1,972 | 2,304 | 3,075 |
| TOTAL | $3,465 | $3,461 | $1,972 | $2,304 | $3,075 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,465 | $3,461 | $1,972 | $2,304 | $3,075 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,709 | 8,923 | 8,923 | 8,919 | 8,903 |
| Common Shares | 11 | 9 | 9 | 9 | 9 |
| Retained earnings | -447,017 | -443,180 | -440,871 | -438,679 | -436,286 |
| TOTAL | $18,558 | $7,450 | $9,703 | $11,788 | $14,053 |
| Total Liabilities And Equity | $22,023 | $10,910 | $11,675 | $14,092 | $17,127 |